For subscribers
Health Sciences Authority ensures safety, quality and efficacy of health products
Sign up now: Get ST's newsletters delivered to your inbox
HSA's regulatory agility and flexibility ensured that Singapore was among the earliest to access Covid-19 vaccines, therapies and medical devices.
ST PHOTO: NG SOR LUAN
SINGAPORE – Singapore has been praised for how quickly and decisively it acted in identifying potential Covid-19 vaccines and buying enough of them in advance for its population.
As the health authorities raced to secure supplies, Singapore’s Health Sciences Authority (HSA) stepped in to review the clinical trial data to make sure they were safe and effective.
